Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials.

Details

Language :

English

ISSN :

11778881

Volume :

11

Database :

Complementary Index

Journal :

Drug Design, Development & Therapy

Publication Type :

Academic Journal

Accession number :

126645651

Full Text :

https://doi.org/10.2147/DDDT.S151269